Maternal high-fat diet is associated with impaired fetal lung development

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 309, Issue 4, 2015, Pages L360-L368

  Mayor, Reina S ^a   Finch, Katelyn E ^a   Zehr, Jordan ^a   Morselli, Eugenia ^a   Neinast, Michael D ^a   Frank, Aaron P ^a   Hahner, Lisa D ^a   Wang, Jason ^a   Rakheja, Dinesh ^a   Palmer, Biff F ^a   Rosenfeld, Charles R ^a   Savani, Rashmin C ^a   Clegg, Deborah J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Chorioamnionitis; Fetal growth restriction; Intrauterine growth restriction; Placental inflammation; Respiratory distress syndrome

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENVIRONMENTAL EXPOSURE; EPIDEMIC; EXPOSURE; FEMALE; FETAL GROWTH RESTRICTION; FETUS GROWTH; FETUS LUNG; LIPID DIET; LUNG DEVELOPMENT; MALE; MATERNAL NUTRITION; MOUSE; NONHUMAN; OBESITY; PERINATAL PERIOD; PLACENTA INSUFFICIENCY; POSTNATAL EXPOSURE; PRENATAL EXPOSURE; PRIORITY JOURNAL; ADVERSE EFFECTS; ANIMAL; BLOOD; C57BL MOUSE; EMBRYOLOGY; FETAL GROWTH RETARDATION; GLUCOSE BLOOD LEVEL; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INFLAMMATION; LUNG; METABOLISM; PATHOLOGY; PLACENTA; PREGNANCY; WEIGHT GAIN;

GLUCOSE BLOOD LEVEL; INSULIN;

ANIMALS; BLOOD GLUCOSE; DIET, HIGH-FAT; FEMALE; FETAL GROWTH RETARDATION; INFLAMMATION; INSULIN; LUNG; MALE; MICE, INBRED C57BL; PLACENTA; PREGNANCY; WEIGHT GAIN;

EID: 84939426903     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00105.2015     Document Type: Article

References (40)

1. Ather JL, Ckless K, Martin R, Foley KL, Suratt BT, Boyson JE, Fitzgerald KA, Flavell RA, Eisenbarth SC, Poynter ME. Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice. J Immunol 187: 64–73, 2011.
2. Barker DJ. The developmental origins of adult disease. J Am Coll Nutr 23: 588S–595S, 2004.
3. Beato M. Gene regulation by steroid hormones. Cell 56: 335–344, 1989.
4. Bose C, Van Marter LJ, Laughon M, O’Shea TM, Allred EN, Karna P, Ehrenkranz RA, Boggess K, Leviton A. Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation. Pediatrics 124: e450–e458, 2009.
5. Calkins K, Devaskar SU. Fetal origins of adult disease. Curr Probl Pediatr Adolesc Health Care 41: 158–176, 2011.
6. Cheong H, Wu J, Gonzales LK, Guttentag SH, Thompson CB, Lindsten T. Analysis of a lung defect in autophagy-deficient mouse strains. Autophagy 10: 45–56, 2014.
7. Christensen HD, Sienko AE, Rayburn WF, Gonzalez CL, Coleman FH. A placebo-controlled, blinded comparison between betamethasone and dexamethasone to enhance lung maturation in the fetal mouse. J Soc Gynecol Investig 4: 130–134, 1997.
8. Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K, Schutz G. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 9: 1608–1621, 1995.
9. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y, Keshet E, Lupu F, Nemery B, Dewerchin M, Van Veldhoven P, Plate K, Moons L, Collen D, Carmeliet P. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 8: 702–710, 2002.
10. Cunningham FGMP, Leveno KJ, Gant NF, Gilstrap LC. Williams Obstetrics. London, UK: Prentice-Hall International, 1993.
11. Curle DC, Adamson IY. Retarded development of noenatal rat lung by maternal malnutrition. J Histochem Cytochem 26: 401–408, 1978.
12. Demayo F, Minoo P, Plopper CG, Schuger L, Shannon J, Torday JS. Mesenchymal-epithelial interactions in lung development and repair: are modeling and remodeling the same process? Am J Physiol Lung Cell Mol Physiol 283: L510–L517, 2002.
13. Dishop MK. Diagnostic Pathology of Diffuse Lung Disease in Children. Pediatr Allergy Immunol Pulmonol 23: 69–85, 2010.
14. Frias AE, Morgan TK, Evans AE, Rasanen J, Oh KY, Thornburg KL, Grove KL. Maternal high-fat diet disturbs uteroplacental hemodynamics and increases the frequency of stillbirth in a nonhuman primate model of excess nutrition. Endocrinology 152: 2456–2464, 2011.
15. Hay W, Thureen P, Anderson M. Intrauterine growth restriction. Neo-Reviews 2: 2001.
16. Hogmalm A, Bry M, Strandvik B, Bry K. IL-1beta expression in the distal lung epithelium disrupts lung morphogenesis and epithelial cell differentiation in fetal mice. Am J Physiol Lung Cell Mol Physiol 306: L23–L34, 2014.
17. Kalinichenko V, Kenny A, Perl A.-K., Shannon J, Wert S, Whitsett J, Xu Y. Lung Morphogenesis. [June 1, 2014, 1999–2014].
18. Kamimae-Lanning AN, Krasnow SM, Goloviznina NA, Zhu X, Roth-Carter QR, Levasseur PR, Jeng S, McWeeney SK, Kurre P, Marks DL. Maternal high-fat diet and obesity compromise fetal hematopoiesis. Mol Metab 4: 25–38, 2015.
19. King G, Damas JE, Cake MH, Berryman D, Maker GL. Influence of glucocorticoids, neuregulin-1beta, and sex on surfactant phospholipid secretion from type II cells. Am J Physiol Lung Cell Mol Physiol 306: L292–L298, 2014.
20. Klinger S, Turgeon B, Levesque K, Wood GA, Aagaard-Tillery KM, Meloche S. Loss of Erk3 function in mice leads to intrauterine growth restriction, pulmonary immaturity, and neonatal lethality. Proc Natl Acad Sci USA 106: 16710–16715, 2009.
21. Kramer BW. Antenatal inflammation and lung injury: prenatal origin of neonatal disease. J Perinatol 28, Suppl 1: S21–S27, 2008.
22. Kramer BW, Kallapur S, Newnham J, Jobe AH. Prenatal inflammation and lung development. Semin Fetal Neonatal Med 14: 2–7, 2009.
23. Lykkedegn S, Sorensen GL, Beck-Nielsen SS, Christesen HT. The impact of vitamin D on fetal and neonatal lung maturation. A systematic review. Am J Physiol Lung Cell Mol Physiol 308: L587–L602, 2015.
24. Manwani N, Gagnon S, Post M, Joza S, Muglia L, Cornejo S, Kaplan F, Sweezey NB. Reduced viability of mice with lung epithelial-specific knockout of glucocorticoid receptor. Am J Respir Cell Mol Biol 43: 599–606, 2010.
25. Maritz GS, Morley CJ, Harding R. Early developmental origins of impaired lung structure and function. Early Hum Dev 81: 763–771, 2005.
26. Mestan KK, Steinhorn RH. Fetal origins of neonatal lung disease: understanding the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 301: L858–L859, 2011.
27. Muglia LJ, Bae DS, Brown TT, Vogt SK, Alvarez JG, Sunday ME, Majzoub JA. Proliferation and differentiation defects during lung development in corticotropin-releasing hormone-deficient mice. Am J Respir Cell Mol Biol 20: 181–188, 1999.
28. National Institutes of Health Consensus Development Panel. Antenatal corticosteroids revisited: repeat courses. National Institutes of Health Consensus Development Conference Statement, August 17–18, 2000. Obstet Gynecol 98: 144–150, 2001.
29. Niemi K, Teirila L, Lappalainen J, Rajamaki K, Baumann MH, Oorni K, Wolff H, Kovanen PT, Matikainen S, Eklund KK. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway. J Immunol 186: 6119–6128, 2011.
30. Oshika E, Liu S, Ung LP, Singh G, Shinozuka H, Michalopoulos GK, Katyal SL. Glucocorticoid-induced effects on pattern formation and epithelial cell differentiation in early embryonic rat lungs. Pediatr Res 43: 305–314, 1998.
31. Polin R, William Fox W, Steven Abman H. Fetal and Neonatal Physiology. Philadelphia, PA: Saunders, 2004.
32. Rogers LK, Valentine CJ, Pennell M, Velten M, Britt RD, Dingess K, Zhao X, Welty SE, Tipple TE. Maternal docosahexaenoic acid supplementation decreases lung inflammation in hyperoxia-exposed newborn mice. J Nutr 141: 214–222, 2011.
33. Rozance PJ, Seedorf GJ, Brown A, Roe G, O’Meara MC, Gien J, Tang JR, Abman SH. Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep. Am J Physiol Lung Cell Mol Physiol 301: L860–L871, 2011.
34. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116: 3015–3025, 2006.
35. Tyson JE, Kennedy K, Broyles S, Rosenfeld CR. The small for gestational age infant: accelerated or delayed pulmonary maturation? Increased or decreased survival? Pediatrics 95: 534–538, 1995.
36. Velten M, Britt RD Jr, Heyob KM, Tipple TE, Rogers LK. Maternal dietary docosahexaenoic acid supplementation attenuates fetal growth restriction and enhances pulmonary function in a newborn mouse model of perinatal inflammation. J Nutr 144: 258–266, 2014.
37. Warburton D, Schwarz M, Tefft D, Flores-Delgado G, Anderson KD, Cardoso WV. The molecular basis of lung morphogenesis. Mech Dev 92: 55–81, 2000.
38. Whitsett JA, Weaver TE. Hydrophobic surfactant proteins in lung function and disease. N Engl J Med 347: 2141–2148, 2002.
39. Woods AaE Roy. Laboratory Histopathology, A Complete Reference. New York, NY: Churchill-Livingston, 1996.
40. Yamamoto KR. Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet 19: 209–252, 1985.